232 related articles for article (PubMed ID: 19465957)
1. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
2. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
[No Abstract] [Full Text] [Related]
3. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
Aksoy S; Karaca B; Dinçer M; Yalçin S
Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
[No Abstract] [Full Text] [Related]
4. Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
[No Abstract] [Full Text] [Related]
5. Capecitabine-associated coronary vasospasm: a case report.
Papadopoulos CA; Wilson H
Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
[TBL] [Abstract][Full Text] [Related]
6. Acute coronary syndrome induced by capecitabine therapy.
Wijesinghe N; Thompson PI; McAlister H
Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
[TBL] [Abstract][Full Text] [Related]
7. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
8. Capecitabine induced colitis.
Maggo G; Grover SC; Grin A
Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
Saadati H; Saif MW
JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
[No Abstract] [Full Text] [Related]
10. Capecitabine-induced cerebellar toxicity.
Renouf D; Gill S
Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
[TBL] [Abstract][Full Text] [Related]
11. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão VV; Feio AB
Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
[No Abstract] [Full Text] [Related]
12. [Suspected dihydropyrimidine dehydrogenase deficiency in a patient receiving capecitabine as adjuvant chemotherapy after colon resection].
Nagai K; Okuda Y; Ohara Y; Yamamoto M
Gan To Kagaku Ryoho; 2015 Jan; 42(1):127-9. PubMed ID: 25596695
[TBL] [Abstract][Full Text] [Related]
13. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
14. Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
Rashidi A; Man L; Howard JR; Atienza D; Fisher SI
Leuk Lymphoma; 2014 Mar; 55(3):683-4. PubMed ID: 23837492
[No Abstract] [Full Text] [Related]
15. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
16. Capecitabine-induced terminal ileitis.
Al-Gahmi AM; Kerr IG; Zekri JM; Zagnoon AA
Ann Saudi Med; 2012; 32(6):661-2. PubMed ID: 23396034
[No Abstract] [Full Text] [Related]
17. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
18. [The prevention of diarrhea while under capecitabine therapy].
Grouls V
Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
[No Abstract] [Full Text] [Related]
19. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
Bel B; Lorton MH; Darut-Jouve A; Vabres P
Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
[No Abstract] [Full Text] [Related]
20. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
